Flamel Technologies S.A. (ADR) Stock Nasdaq
Equities
US3384881096
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2024 * | 162M | Sales 2025 * | 293M | Capitalization | 1.61B |
---|---|---|---|---|---|
Net income 2024 * | -32M | Net income 2025 * | 91M | EV / Sales 2024 * | 9.79 x |
Net cash position 2024 * | 27.06M | Net cash position 2025 * | 95.46M | EV / Sales 2025 * | 5.18 x |
P/E ratio 2024 * |
-257
x | P/E ratio 2025 * |
7.27
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.1% |
Latest transcript on Flamel Technologies S.A. (ADR)
Managers | Title | Age | Since |
---|---|---|---|
Gregory Divis
CEO | Chief Executive Officer | 57 | 17-01-02 |
Thomas McHugh
DFI | Director of Finance/CFO | 59 | 19-12-01 |
Scott Macke
COO | Chief Operating Officer | - | 14-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Ende
BRD | Director/Board Member | 55 | 18-11-30 |
Gregory Divis
CEO | Chief Executive Officer | 57 | 17-01-02 |
Mark McCamish
BRD | Director/Board Member | 72 | 19-12-04 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B |